We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$472M
AUM Growth
+$13.1M
Cap. Flow
-$31.7M
Cap. Flow %
-6.72%
Top 10 Hldgs %
38.2%
Holding
121
New
18
Increased
23
Reduced
34
Closed
15

Top Buys

Rank Stock Value
1
ETFC
E*Trade Financial Corporation
ETFC
+$8.46M
2
PFPT
Proofpoint, Inc.
PFPT
+$8.34M
3
HQY icon
HealthEquity
HQY
+$7.79M
4
ICUI icon
ICU Medical
ICUI
+$6.78M
5
FTNT icon
Fortinet
FTNT
+$6.43M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$12.3M
2
PNC icon
PNC Financial Services
PNC
+$11.8M
3
MKSI icon
MKS Inc
MKSI
+$8.81M
4
MPC icon
Marathon Petroleum
MPC
+$7.8M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.3M

Sector Composition

Rank Sector Weight
1 Technology 34.2%
2 Healthcare 31.64%
3 Financials 15.6%
4 Consumer Discretionary 6.3%
5 Communication Services 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEN icon
51
Penumbra
PEN
$12.5B
$2.29M 0.49%
+16,600
New +$2.36M
SBUX icon
52
Starbucks
SBUX
$118B
$2.27M 0.48%
46,500
-500
-1% -$28.4K
MMM icon
53
3M
MMM
$87.5B
$2.26M 0.48%
13,767
+222
+2% +$37.9K
CHD icon
54
Church & Dwight Co
CHD
$22.8B
$2.19M 0.46%
41,200
– –
SUPN icon
55
Supernus Pharmaceuticals
SUPN
$2.74B
$2.18M 0.46%
+36,500
New +$1.89M
PAYC icon
56
Paycom
PAYC
$6.47B
$2.08M 0.44%
21,000
-26,000
-55% -$2.8M
ATO icon
57
Atmos Energy
ATO
$29.7B
$2.01M 0.43%
22,300
-1,000
-4% -$86.6K
MASI
58
DELISTED
Masimo
MASI
$1.96M 0.42%
20,100
– –
AMN icon
59
AMN Healthcare
AMN
$1.28B
$1.96M 0.41%
+33,400
New +$1.99M
GILD icon
60
Gilead Sciences
GILD
$162B
$1.86M 0.39%
26,275
-900
-3% -$63.6K
GMED icon
61
Globus Medical
GMED
$10.2B
$1.81M 0.38%
+35,800
New +$1.87M
CCI icon
62
Crown Castle
CCI
$32.5B
$1.76M 0.37%
16,350
-2,000
-11% -$208K
CGNX icon
63
Cognex
CGNX
$10.6B
$1.75M 0.37%
39,300
-100
-0.3% -$4.73K
VZ icon
64
Verizon
VZ
$183B
$1.71M 0.36%
34,015
+366
+1% +$17.7K
NBIX icon
65
Neurocrine Biosciences
NBIX
$17.5B
$1.66M 0.35%
16,900
– –
MPC icon
66
Marathon Petroleum
MPC
$91.2B
$1.56M 0.33%
22,300
-102,100
-82% -$7.8M
ESRX
67
DELISTED
Express Scripts Holding Company
ESRX
$1.49M 0.32%
19,355
– –
SCHW
68
Charles Schwab
SCHW
$177B
$1.48M 0.31%
+29,000
New +$1.61M
NKE icon
69
Nike
NKE
$60.8B
$1.38M 0.29%
17,300
– –
MAS icon
70
Masco
MAS
$15.6B
$1.35M 0.29%
36,050
-200
-0.6% -$7.7K
JNJ icon
71
Johnson & Johnson
JNJ
$624B
$1.29M 0.27%
10,650
-100
-0.9% -$12.5K
CTSH icon
72
Cognizant
CTSH
$20.3B
$1.26M 0.27%
16,008
+208
+1% +$16.4K
T icon
73
AT&T
T
$160B
$1.17M 0.25%
+48,207
New +$1.21M
C icon
74
Citigroup
C
$221B
$1.08M 0.23%
16,082
– –
BFAM icon
75
Bright Horizons
BFAM
$3.91B
$1.05M 0.22%
10,300
– –
1 2
3
4 5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q2 2018 Portfolio in Review

As of Q2 2018, De Burlo Group held 121 positions worth $472M, up 2.8% from $459M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

De Burlo Group withdrew a net $31.7M in Q2 2018, closing 15 positions and reducing 34 holdings. Its most notable exit was JPMorgan Chase, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, De Burlo Group opened a new position in HealthEquity worth $8.14M.

  • De Burlo Group's largest Q2 2018 buy was HealthEquity: 108,450 shares worth $8.14M.
  • De Burlo Group added most to E*Trade Financial Corporation in Q2 2018, an estimated $8.46M increase.
  • De Burlo Group's biggest Q2 2018 reduction was MKS Inc, cutting an estimated $8.81M.
  • De Burlo Group fully exited JPMorgan Chase in Q2 2018, selling an estimated $12.3M.
  • De Burlo Group's ten largest holdings make up 38% of its $472M portfolio in Q2 2018.
  • De Burlo Group opened 18 new positions and closed 15 in Q2 2018.
  • De Burlo Group's portfolio value rose 2.8% quarter-over-quarter to $472M.

Based on De Burlo Group's 13F filing for Q2 2018, filed 10 Aug 2018.